|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00460 SIHUAN PHARM
Nominal 
1.670 -0.010 (-0.595%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 1,146,203 | 20.691% | 949,697 | 1,055,705 | 1,464,197 | 1,907,219 |
| Cost of Sales | (388,947) | 14.000% | (341,181) | (307,972) | (460,508) | (440,096) |
| Gross Profit | 757,256 | 24.443% | 608,516 | 747,733 | 1,003,689 | 1,467,123 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | (98,097) | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (2,486) | -- | 4,144 | (45,672) | (47,733) | (50,699) | |
| Profit / (Loss) before Taxation | 156,924 | -- | (19,212) | (33,054) | 56,042 | 819,483 | |
| Taxation | (90,730) | 86.128% | (48,746) | (85,886) | (151,943) | (225,265) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 36,409 | 5.429% | 34,534 | 69,296 | 136,277 | 17,206 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 102,603 | -- | (33,424) | (49,644) | 40,376 | 611,424 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 55,376 | -5.536% | 58,621 | 56,094 | 25,259 | (52,942) |
| Depreciation & Amortisation | -- | -- | -- | 122,327 | 179,022 | -- |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | 1.110 | -- | -0.360 | -0.530 | 0.430 | 6.460 |
| DPS (cts) | 0.990 | -- | 1.900 | 0.000 | 3.300 | 0.000 |
| Dividend Payout Ratio (%) | 89.189% | -- | -- | -- | 767.442% | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 0.477 | -- | 0.474 | 0.472 | 0.778 | 1.041 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 102,603 |
| %Change | -- |
| EPS / (LPS) | RMB 0.011 |
| NBV Per Share (¥) | RMB 0.477 |